Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Jaguar Health, Inc.
organization5 mentionslast seen Oct 5, 2026
A Delaware corporation traded on Nasdaq under the ticker JAGX.
Relationships 7
- Jaguar Health, Inc.employsLisa A. Conte99% confidence5 sources
- Jaguar Health, Inc.acquiresNapo Therapeutics S.p.A.95% confidence1 source
- Jaguar Health, Inc.ownsNapo Pharmaceuticals, Inc.95% confidence1 source
- Jaguar Health, Inc.developscrofelemer93% confidence1 source
- C/M Capital Master Fund, LPinvests inJaguar Health, Inc.90% confidence1 source
- Streeterville Capital, LLCinvests inJaguar Health, Inc.90% confidence1 source
- Jaguar Health, Inc.funded byStreeterville Capital, LLC85% confidence1 source
Relationship
Jaguar Health, Inc.employsLisa A. Conte
99% confidence5 supporting mentions
Either name opens that entity’s relationships.
Sources 5
- filingSEC EDGAROct 5, 2026Jaguar Health, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Item 3.03: Material Modifications to Rights of Security Holders; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Lisa Conte, Jaguar's founder, president, and CEO
- filingSEC EDGARSep 28, 2026Jaguar Health, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Lisa A. Conte ... Title: President and Chief Executive Officer
- filingSEC EDGARSep 24, 2026Jaguar Health, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 1.02: Termination of a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Lisa A. Conte, President and Chief Executive Officer
- filingSEC EDGARSep 24, 2026Jaguar Health, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Lisa A. Conte Title: President and Chief Executive Officer
- filingSEC EDGARSep 15, 2026Jaguar Health, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
Lisa A. Conte Chief Executive Officer & President